<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; DCP</title>
	<atom:link href="http://www.stockbloghub.com/tag/dcp/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(DARA) DARA BioSciences&#8217; KRN5500 Data Looks Strong</title>
		<link>http://www.stockbloghub.com/2010/09/09/dara-dara-biosciences-krn5500-data-looks-strong/50979</link>
		<comments>http://www.stockbloghub.com/2010/09/09/dara-dara-biosciences-krn5500-data-looks-strong/50979#comments</comments>
		<pubDate>Fri, 10 Sep 2010 06:10:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[DARA]]></category>
		<category><![CDATA[DARA BioSciences Inc]]></category>
		<category><![CDATA[DCP]]></category>
		<category><![CDATA[DPN]]></category>
		<category><![CDATA[DynCorp International Inc]]></category>
		<category><![CDATA[Navigant Consulting Inc.]]></category>
		<category><![CDATA[NCI]]></category>
		<category><![CDATA[SU]]></category>
		<category><![CDATA[Suncor Energy Inc]]></category>
		<category><![CDATA[WisdomTree International Cons Staples]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=50979</guid>
		<description><![CDATA[KRN5500 Data Looks Strong On September 8, 2010, DARA BioSciences (DARA) presented positive study results from its phase II dose escalation study with KRN5500 at the 13th World Congress on Pain. The multicenter, placebo-controlled phase II study was designed to evaluate the safety and efficacy of KRN5500 for treatment of neuropathic pain in patients with cancer. Management used the Wilcoxon Rank Sum test to compare treatment differences in median changes from baseline in pain scores recorded by patients in a daily diary. Results show: KRN5500 significantly reduced neuropathic pain when compared to placebo (27% vs. 0%; p = 0.03) when looking at best response to treatment regardless of dose or timing. For the best response within 7 days of last treatment given, the difference was in favor of KRN5500, but ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/09/dara-dara-biosciences-krn5500-data-looks-strong/50979/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WLP) WellPoint Earnings Beat &#8211; Raises Outlook</title>
		<link>http://www.stockbloghub.com/2010/07/28/wlp-wellpoint-earnings-beat-raises-outlook/45097</link>
		<comments>http://www.stockbloghub.com/2010/07/28/wlp-wellpoint-earnings-beat-raises-outlook/45097#comments</comments>
		<pubDate>Wed, 28 Jul 2010 18:56:41 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[DCP]]></category>
		<category><![CDATA[DynCorp International Inc]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=45097</guid>
		<description><![CDATA[On July 28, 2010, WellPoint Inc. (WLP) reported its second-quarter income from continuing operations of $702.8 million or $1.67 per share, surpassing the Zacks Consensus Estimate of $1.56. This also compares favorably with the income of $731.5 million or earnings of $1.50 in the year-ago quarter. The improved showing was attributable to higher-than-expected favorable reserve development and continued strong performance in capital management. WellPoint’s income from continuing operations excludes net investment gains of $19.6 million after-tax, or $0.04 per share in the reported quarter and net investment losses of $38.0 million after-tax or $0.07 per share in the prior-year quarter. Including these one-time items, WellPoint reported a net income of $722.4 million or $1.71 per share as opposed to $693.5 million or $1.43 per share. Behind the Headlines Total operating ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/28/wlp-wellpoint-earnings-beat-raises-outlook/45097/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WIT) Wipro Limited Announces Strategic Retailing Solutions</title>
		<link>http://www.stockbloghub.com/2010/01/15/wit-wipro-limited-announces-strategic-retailing-solutions/25087</link>
		<comments>http://www.stockbloghub.com/2010/01/15/wit-wipro-limited-announces-strategic-retailing-solutions/25087#comments</comments>
		<pubDate>Sat, 16 Jan 2010 00:25:42 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Business Software & Services]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[DCP]]></category>
		<category><![CDATA[DynCorp International Inc]]></category>
		<category><![CDATA[Infosys Technologies Limited]]></category>
		<category><![CDATA[INFY]]></category>
		<category><![CDATA[Wipro Limited]]></category>
		<category><![CDATA[WIT]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=25087</guid>
		<description><![CDATA[Wipro Technologies, the global IT services business of Wipro Limited (WIT), announced the launch of two strategic retail solutions, Digital Customer Experience Platform and Loss Prevention Platform. Wipro’s Digital Customer Experience Platform (DCP) is a comprehensive solution designed to enable retailers manage their online business in an integrated manner. It is a pioneering effort to integrate social media, community features and personalization for providing an engaging customer experience. Wipro’s Loss Prevention (LP) Platform is a complete shrink management solution that provides retailers an integrated view across the entire shrink management lifecycle. The platform packs in an analytics suite that helps retailers prevent fraud by leveraging predictive modeling. Wipro’s Digital Customer Experience and Loss Prevention platform provides an integrated toolset that enables retailers to leverage these trends. Wipro continues to innovate ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/15/wit-wipro-limited-announces-strategic-retailing-solutions/25087/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

